Manchester, England, United Kingdom Acceleris Capital is the famous VC, which was founded in 2000. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the Manchester.
The current fund was established by Norman Molyneux. The overall number of key employees were 2.
The fund is generally included in less than 2 deals every year. Opposing the other organizations, this Acceleris Capital works on 11 percentage points less the average amount of lead investments. The important activity for fund was in 2017. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2015. The common things for fund are deals in the range of 1 - 5 millions dollars.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Acceleris Capital, startups are often financed by Enterprise Ventures, Development Bank of Wales, The Welsh Government. The meaningful sponsors for the fund in investment in the same round are Seneca Partners, Development Bank of Wales, Enterprise Ventures. In the next rounds fund is usually obtained by Development Bank of Wales, Seneca Partners, UK Innovation & Science Seed Fund.
Among the most popular portfolio startups of the fund, we may highlight Evgen Pharma, Redag Crop Protection, Femeda. Among the most successful fund investment fields, there are Health Care, Chemical. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
Related Funds
| Fund Name | Location |
| 33 Capital | - |
| Afone Participations | France, Ile-de-France, Paris |
| Althelia Funds | England, London, United Kingdom |
| BioNet Holding | Bayern, Germany, Martinsried |
| Chenhui Wangsu Investment | China, Shanghai |
| Chuangwu Touzi | China, Guangdong, Shenzhen |
| Claritas Capital | Nashville, Tennessee, United States |
| Cosan S.A. | Brazil, São Paulo, Sao Paulo |
| Dig Ventures | England, London, United Kingdom |
| Guotai Junan Innovation Investment | China, Shanghai |
| Huazhang Touzi | Beijing, Beijing, China |
| iSun Energy | United States, Vermont, Williston |
| Iyo Bank Capital | Ehime Prefecture, Japan, Matsuyama |
| Lingfeng Capital | Beijing, Beijing, China |
| M6 Ventures | California, La Jolla, United States |
| Myrlid AS | - |
| Needham Bank | Massachusetts, Massachusetts, United States |
| Redhawk Investors | - |
| Scale Investors | Australia, Melbourne, Victoria |
| Shanghai Yuanrui Touzi Hehuoqiye (Youxian Hehuo) | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vertical Future | $5M | 08 Oct 2019 | England | ||
EveryCloud Technologies | 01 Jan 2015 | San Jose, California, United States | |||
| 24 Oct 2014 | United Kingdom, England, United Kingdom | ||||
Reacta Biotech | 01 Feb 2014 | United Kingdom, England | |||
Microvisk Technologies | 01 Jan 2006 | St Asaph, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vertical Future | $5M | 08 Oct 2019 | England | ||
EveryCloud Technologies | 01 Jan 2015 | San Jose, California, United States | |||
| 24 Oct 2014 | United Kingdom, England, United Kingdom | ||||
Reacta Biotech | 01 Feb 2014 | United Kingdom, England | |||
Microvisk Technologies | 01 Jan 2006 | St Asaph, United Kingdom |
